- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02645110
Evaluation of Effectiveness and Mildness of Whole-natural Hand-wash Formulations
December 31, 2015 updated by: Mother's Choice Ltd
Openly, Controlled Interventional Trial for Evaluating the Effectiveness of Whole-natural Hand-wash Formulations in Bacterial Removal and Openly Randomized Trial for Estimating the Relative Mildness of the Formulations
The purpose of this study is to evaluate the effectiveness of whole-natural hand-wash formulations in bacterial removal and to estimate the relative mildness of the formulations.
Study Overview
Status
Unknown
Conditions
Intervention / Treatment
Detailed Description
Hand washing with soap and water is one of the main ways to prevent the spread of diseases in general and specifically, the spread of hospital-acquired diseases.
Mother's Choice Company develops natural products and technologies which include hand-wash soap.
The purpose of this project is developing a whole-natural hand wash soap including no harmful ingredients which will succeed to remove at least 99.9% (3 log reduction) of the hand transient microbiota.
In addition, the soap will be mild enough to allow the use of dozens times a day.
The procedure for evaluating soap effectiveness in bacterial removal will include in general: bacterial application on hands, hand washing with the tested soap, sampling of hands before and after hand washing.
The procedure for soap mildness estimation will include exposure of specific area of the arm or the back skin to the soap and following up and grading the reaction of the skin.
Study Type
Interventional
Enrollment (Anticipated)
100
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Jerusalem, Israel, 9139102
- Mother's Choice LTD
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years to 60 years (Adult)
Accepts Healthy Volunteers
Yes
Genders Eligible for Study
All
Description
Inclusion Criteria:
For effectiveness test:
- Healthy subjects aged 18-60 (both sexes).
- Subjects must have short natural nails.
- Subjects must remove all jewelry from their hands and forearms before participating.
- Subjects must not expose their hands to any antimicrobial products for 24 hours before the test (including antimicrobial containing dish soaps, shampoos, and body washes).
- Subjects must don safety glasses and lab coat prior to participating.
- Subjects will not be exposed to more than one challenge microorganisms per week and more than five challenge microorganisms in total.
For mildness test:
- Subject aged 18-60
- Subjects should be healthy adults from both sexes (preferably more women than men)
- Subjects would be able to participate in one study per four weeks.
Exclusion Criteria
For effectiveness test:
- Subjects cannot have any breaks or cuts in the skin of the hands or forearms.
- Subjects cannot have a medical diagnosis of a physical condition.
- Subjects cannot have allergies to detergents, hand hygiene products, perfume or any other substance they are going to be expose to.
- Subjects must not be on antibiotics or have been on antibiotics in the past 14 days.
- Subjects cannot participate if they have participated in other clinical trials within the past 14 days.
- Subjects cannot have any other general health or skin issues not mentioned above.
- Subjects cannot be pregnant or nursing.
For mildness test:
- pregnant or nursing subjects
- Subjects with an allergy or a skin disease which interferes with the proper results of the tests.
- Subjects who are taking medications which can interfere with the proper results of the tests. For example: systemic corticosteroids, topical steroids applied to the test area.
- Subjects with sun or phototherapy induced tanning at the test area.
- Subject who had been participating in allergy tests within four weeks prior to the present tests.
- Subjects could not use cosmetics for the face area except for the use of lipstick and makeup around the eyes for two weeks before the test.
- Subjects can use only mild soap and no more than once a day.
- Subjects should avoid drinking alcohol, coffee, tea and smoking on the test day.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Prevention
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: MC Hand soap
For bacterial removal trial: Hand washing with the tested soap following bacterial application
|
Washing hand with soap in comparison to hand washing with water alone
|
|
Sham Comparator: Water
For bacterial removal trial: Hand washing with tap water alone following bacterial application
|
Washing hand with water alone in comparison to hand washing with soap
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
The efficacy of the tested hand-wash soaps in bacterial removal, presented as Log reduction
Time Frame: one year
|
For log reduction determination the bacterial counts will be converted to log10.
Next, the final quantity of bacteria recovered from hands after washing hands with the tested soap will be reduced from the start quantity of bacteria that was recovered from hands after bacterial application (before washing hands).
For each soap the log reduction of each subject and the average log reduction will be presented.
|
one year
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: Allon Moses, MD, Hadassah Medical Organization
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
January 1, 2016
Primary Completion (Anticipated)
March 1, 2016
Study Completion (Anticipated)
January 1, 2017
Study Registration Dates
First Submitted
December 27, 2015
First Submitted That Met QC Criteria
December 31, 2015
First Posted (Estimate)
January 1, 2016
Study Record Updates
Last Update Posted (Estimate)
January 1, 2016
Last Update Submitted That Met QC Criteria
December 31, 2015
Last Verified
December 1, 2015
More Information
Terms related to this study
Other Study ID Numbers
- 0602-15-HMO
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
YES
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Skin Irritation
-
Galderma R&DCompleted
-
University Hospitals Cleveland Medical CenterNational Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) and other collaboratorsCompleted
-
Ventrus Biosciences, IncUnknownSkin IrritationUnited States
-
Repolar Pharmaceuticals OyPrinceton Consumer ResearchCompletedSkin Sensitization | Skin IrritationUnited Kingdom
-
Galderma R&DCompletedSkin IrritationUnited States
-
Corium, Inc.CompletedSkin Irritation | SensitizationUnited States
-
Galderma R&DCompletedSkin IrritationUnited States
-
Sheri Kashmir Institute of Medical SciencesCompletedCough | Irritation in Throat | Irritation in Skin | LacrimationIndia
-
Ludwig-Maximilians - University of MunichCompletedBest Comfort and Lowest Skin IrritationGermany
-
Galderma R&DCompletedSkin IrritationUnited States
Clinical Trials on MC Hand Soap
-
Ethiopian Institute of Water ResourcesCompleted
-
Mekelle UniversityUniversity of Alcala; Maastricht UniversityCompletedAnaemia | Intestinal Parasitic InfectionsEthiopia
-
University of California, San DiegoCompleted
-
Finnish Institute for Health and WelfareFinnish Defense ForcesSuspended
-
London School of Hygiene and Tropical MedicineUnited States Agency for International Development (USAID); Kelkar Education... and other collaboratorsCompletedEscherichia Coli ChangeIndia
-
University Hospital, GenevaWorld Health Organization; AIC Kijabe HospitalCompletedPostoperative Wound InfectionKenya
-
University of Cape TownAbdul Latif Jameel Poverty Action LabCompletedDiarrhea | Hand-washing Behavior
-
Region SkaneZimmer BiometActive, not recruiting
-
Fundación Pública Andaluza para la Investigación...Ministry of Health, SpainCompletedRespiratory Tract Infections | Gastroenteritis
-
International Centre for Diarrhoeal Disease Research...State University of New York at BuffaloCompleted